PUBLISHER: Grand View Research | PRODUCT CODE: 1908496
PUBLISHER: Grand View Research | PRODUCT CODE: 1908496
The global microfluidics market size was estimated at USD 41.92 billion in 2025 and is projected to reach USD 105.13 billion by 2033, growing at a CAGR of 12.22% from 2026 to 2033. This growth is primarily driven by the increasing adoption of microfluidic devices across various fields of research and diagnostics.
Advancements and Adoption of Microfluidics in Diagnostic Healthcare
The demand for reliable diagnostic tools is increasing due to the soaring hospital charges and frequent patient readmissions, while prehospital and point-of-care (POC) solutions, including at-home monitoring, are minimizing hospital visits and inpatient stays. Major players such as Abbott, Roche, and Danaher are pushing the growth of the IVD market by incorporating microfluidics into their diagnostic platforms for earlier disease detection, faster turnaround times, enhanced accuracy, and, at the same time, non-invasive sampling.
Microfluidics-enhanced PoCT solutions offer improved sensitivity, specificity, and faster turnaround times, prompting manufacturers to launch microfluidics-based diagnostic kits to address urgent testing needs. For example, in October 2021, LumiraDx received Emergency Use Authorization from India's CDSCO for its COVID-19 antigen test, underscoring the critical role of microfluidics in pandemic response and public health diagnostics.
Global Microfluidics Market Report Segmentation
This report forecasts revenue growth and provides an analysis on the latest trends in each of the sub-segments from 2021 to 2033. For this report, Grand View Research has segmented the microfluidics market report based on product, technology, material, application, and region.